KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Ginkgo Bioworks Holdings filings provide 3 years of Raw Materials readings, the most recent being $905000.0 for Q2 2023.

  • On a quarterly basis, Raw Materials rose 4.87% to $905000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $905000.0, a 4.87% increase, with the full-year FY2022 number at $1.6 million, up 2384.38% from a year prior.
  • Raw Materials hit $905000.0 in Q2 2023 for Ginkgo Bioworks Holdings, down from $2.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.3 million in Q1 2023 to a low of $64000.0 in Q4 2021.
  • Median Raw Materials over the past 3 years was $884000.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Raw Materials: surged 2384.38% in 2022 and later increased 4.87% in 2023.
  • Ginkgo Bioworks Holdings' Raw Materials stood at $64000.0 in 2021, then surged by 2384.38% to $1.6 million in 2022, then plummeted by 43.08% to $905000.0 in 2023.
  • The last three reported values for Raw Materials were $905000.0 (Q2 2023), $2.3 million (Q1 2023), and $1.6 million (Q4 2022) per Business Quant data.